Search
The latest edition of MS News, Summer 2025 (Issue 112), is now available to read online. This issue features a wide range of updates, personal stories, and resources for the MS community.
‘MS News’ is the magazine of MS Ireland. It exists to foster informed debate and comment about all issues relating to MS. You can access issues of MS News by clicking the links below.
Chloe Mitchell shares her inspiring MS blog, ‘I for Inspiring,’ as part of our A to Z of MS series — a story of purpose, resilience, and hope.
By popular demand, our STEPtember Challenge is back!
Join us for a fun and impactful challenge to support MS Ireland. Throughout the month of September, we’re encouraging everyone to take 10,000 steps a day. Whether you're walking, jogging, or running, every step counts towards making a difference.
Sign Up and Get Your STEPtember Pack!
-
Register with enthuse to create a fundraising page https://multiplesclerosisofireland.enthuse.com/cf/steptember-2025
Once registered we will send you out your STEPtember pack including a t-shirt, pen, and tracker sheet to help you stay motivated and on track!
- Then, join our Facebook group here
The All-Ireland Multiple Sclerosis Research Network (AIMS-RN) Symposium took place on Friday 6th June 2025 at Maynooth University, bringing together researchers, clinicians, and professionals from across the island of Ireland to share the latest developments in multiple sclerosis (MS) research.
Our third guest on the Living with MS Podcast is Suzanne Ryder. Suzanne is a new member of the MS & Me Blog team. Listen to the episode here or on your favourite podcast platform.
Weekly Physiotherapist-Led exercise classes for People with MS. Every Tuesday at 10.30am. Classes are held online via zoom. Contact the Regional Office to book in 01-4905933.
MS Ireland is excited to launch a new fundraising initiative — the MS Ireland Lotto — to help support our regional services across the country.
Disease-modifying therapies (DMT's) can affect the course of MS. Although not a cure, disease-modifying therapies act to reduce the number and severity of MS relapses. They also reduce the number of new MS lesions. It is not yet known whether these drugs will slow down the rate of disability in the long-term.